nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxyzine—CYP2D6—Parkinson's disease	0.985	1	CbGaD
Hydroxyzine—Ifenprodil—GRIN2B—Parkinson's disease	0.00159	0.123	CrCbGaD
Hydroxyzine—Acetophenazine—DRD1—Parkinson's disease	0.000848	0.0653	CrCbGaD
Hydroxyzine—Acetophenazine—DRD2—Parkinson's disease	0.000598	0.046	CrCbGaD
Hydroxyzine—Zuclopenthixol—DRD1—Parkinson's disease	0.000537	0.0413	CrCbGaD
Hydroxyzine—Clemastine—CYP2D6—Parkinson's disease	0.000506	0.039	CrCbGaD
Hydroxyzine—Nefazodone—SLC6A3—Parkinson's disease	0.000506	0.0389	CrCbGaD
Hydroxyzine—Prochlorperazine—DRD3—Parkinson's disease	0.000451	0.0347	CrCbGaD
Hydroxyzine—Nefazodone—HTR1A—Parkinson's disease	0.000443	0.0341	CrCbGaD
Hydroxyzine—Trazodone—HTR1A—Parkinson's disease	0.00041	0.0316	CrCbGaD
Hydroxyzine—Zuclopenthixol—DRD2—Parkinson's disease	0.000378	0.0291	CrCbGaD
Hydroxyzine—Perphenazine—HTR7—Parkinson's disease	0.000343	0.0264	CrCbGaD
Hydroxyzine—Quetiapine—HTR7—Parkinson's disease	0.000336	0.0259	CrCbGaD
Hydroxyzine—Cinnarizine—DRD2—Parkinson's disease	0.000325	0.025	CrCbGaD
Hydroxyzine—Perphenazine—DRD1—Parkinson's disease	0.000316	0.0243	CrCbGaD
Hydroxyzine—Quetiapine—DRD3—Parkinson's disease	0.000316	0.0243	CrCbGaD
Hydroxyzine—Prochlorperazine—DRD2—Parkinson's disease	0.000312	0.024	CrCbGaD
Hydroxyzine—Quetiapine—DRD1—Parkinson's disease	0.00031	0.0239	CrCbGaD
Hydroxyzine—Zuclopenthixol—HTR2A—Parkinson's disease	0.000292	0.0225	CrCbGaD
Hydroxyzine—Nefazodone—HTR2A—Parkinson's disease	0.000291	0.0224	CrCbGaD
Hydroxyzine—Flunarizine—CYP2D6—Parkinson's disease	0.00029	0.0223	CrCbGaD
Hydroxyzine—Trazodone—HTR2A—Parkinson's disease	0.000269	0.0207	CrCbGaD
Hydroxyzine—Zuclopenthixol—CYP2D6—Parkinson's disease	0.000267	0.0206	CrCbGaD
Hydroxyzine—Nefazodone—CYP2D6—Parkinson's disease	0.000266	0.0205	CrCbGaD
Hydroxyzine—Perphenazine—HTR1A—Parkinson's disease	0.000263	0.0202	CrCbGaD
Hydroxyzine—Quetiapine—HTR1A—Parkinson's disease	0.000258	0.0198	CrCbGaD
Hydroxyzine—Trazodone—CYP2D6—Parkinson's disease	0.000246	0.0189	CrCbGaD
Hydroxyzine—Cinnarizine—CYP2D6—Parkinson's disease	0.000229	0.0177	CrCbGaD
Hydroxyzine—Perphenazine—DRD2—Parkinson's disease	0.000223	0.0172	CrCbGaD
Hydroxyzine—Prochlorperazine—CYP2D6—Parkinson's disease	0.00022	0.017	CrCbGaD
Hydroxyzine—Quetiapine—DRD2—Parkinson's disease	0.000219	0.0168	CrCbGaD
Hydroxyzine—Nefazodone—ABCB1—Parkinson's disease	0.00019	0.0146	CrCbGaD
Hydroxyzine—Trazodone—ABCB1—Parkinson's disease	0.000176	0.0135	CrCbGaD
Hydroxyzine—Perphenazine—HTR2A—Parkinson's disease	0.000172	0.0133	CrCbGaD
Hydroxyzine—Quetiapine—HTR2A—Parkinson's disease	0.000169	0.013	CrCbGaD
Hydroxyzine—Perphenazine—CYP2D6—Parkinson's disease	0.000158	0.0121	CrCbGaD
Hydroxyzine—Quetiapine—CYP2D6—Parkinson's disease	0.000155	0.0119	CrCbGaD
Hydroxyzine—Quetiapine—ABCB1—Parkinson's disease	0.00011	0.00849	CrCbGaD
Hydroxyzine—CYP2D6—Codeine and Morphine Metabolism—ABCB1—Parkinson's disease	8.62e-05	0.0366	CbGpPWpGaD
Hydroxyzine—CYP2D6—CYP2E1 reactions—CYP2E1—Parkinson's disease	8.56e-05	0.0363	CbGpPWpGaD
Hydroxyzine—HRH1—Monoamine GPCRs—HTR1A—Parkinson's disease	6.78e-05	0.0287	CbGpPWpGaD
Hydroxyzine—HRH1—Monoamine GPCRs—DRD1—Parkinson's disease	6.54e-05	0.0277	CbGpPWpGaD
Hydroxyzine—CYP2D6—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	6.34e-05	0.0269	CbGpPWpGaD
Hydroxyzine—HRH1—Monoamine GPCRs—DRD3—Parkinson's disease	6.34e-05	0.0269	CbGpPWpGaD
Hydroxyzine—HRH1—Monoamine GPCRs—DRD2—Parkinson's disease	5.73e-05	0.0243	CbGpPWpGaD
Hydroxyzine—HRH1—Monoamine GPCRs—HTR7—Parkinson's disease	5.73e-05	0.0243	CbGpPWpGaD
Hydroxyzine—HRH1—Amine ligand-binding receptors—HTR1A—Parkinson's disease	5.7e-05	0.0241	CbGpPWpGaD
Hydroxyzine—HRH1—Amine ligand-binding receptors—DRD1—Parkinson's disease	5.5e-05	0.0233	CbGpPWpGaD
Hydroxyzine—HRH1—Amine ligand-binding receptors—DRD3—Parkinson's disease	5.33e-05	0.0226	CbGpPWpGaD
Hydroxyzine—CYP2D6—Xenobiotics—CYP2E1—Parkinson's disease	5.31e-05	0.0225	CbGpPWpGaD
Hydroxyzine—CYP2D6—Tamoxifen metabolism—CYP2E1—Parkinson's disease	5.1e-05	0.0216	CbGpPWpGaD
Hydroxyzine—HRH1—Amine ligand-binding receptors—DRD2—Parkinson's disease	4.82e-05	0.0204	CbGpPWpGaD
Hydroxyzine—HRH1—Amine ligand-binding receptors—HTR7—Parkinson's disease	4.82e-05	0.0204	CbGpPWpGaD
Hydroxyzine—HRH1—G alpha (q) signalling events—DGKQ—Parkinson's disease	4.18e-05	0.0177	CbGpPWpGaD
Hydroxyzine—HRH1—Monoamine GPCRs—HTR2A—Parkinson's disease	4.01e-05	0.017	CbGpPWpGaD
Hydroxyzine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKQ—Parkinson's disease	3.74e-05	0.0159	CbGpPWpGaD
Hydroxyzine—HRH1—Amine ligand-binding receptors—HTR2A—Parkinson's disease	3.37e-05	0.0143	CbGpPWpGaD
Hydroxyzine—CYP2D6—Melatonin metabolism and effects—MAOA—Parkinson's disease	3.24e-05	0.0138	CbGpPWpGaD
Hydroxyzine—HRH1—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	3.23e-05	0.0137	CbGpPWpGaD
Hydroxyzine—HRH1—G alpha (q) signalling events—GRK5—Parkinson's disease	3.17e-05	0.0134	CbGpPWpGaD
Hydroxyzine—CYP2D6—Melatonin metabolism and effects—EDN1—Parkinson's disease	3.02e-05	0.0128	CbGpPWpGaD
Hydroxyzine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GRK5—Parkinson's disease	2.84e-05	0.012	CbGpPWpGaD
Hydroxyzine—HRH1—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	2.77e-05	0.0117	CbGpPWpGaD
Hydroxyzine—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	2.63e-05	0.0111	CbGpPWpGaD
Hydroxyzine—CYP2D6—Melatonin metabolism and effects—APOE—Parkinson's disease	2.46e-05	0.0104	CbGpPWpGaD
Hydroxyzine—HRH1—G alpha (q) signalling events—GRM5—Parkinson's disease	2.29e-05	0.00972	CbGpPWpGaD
Hydroxyzine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	2.2e-05	0.00934	CbGpPWpGaD
Hydroxyzine—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	2.17e-05	0.00922	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—GPR37—Parkinson's disease	2.11e-05	0.00895	CbGpPWpGaD
Hydroxyzine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GRM5—Parkinson's disease	2.05e-05	0.00869	CbGpPWpGaD
Hydroxyzine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	1.79e-05	0.00758	CbGpPWpGaD
Hydroxyzine—HRH1—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	1.79e-05	0.00757	CbGpPWpGaD
Hydroxyzine—HRH1—G alpha (q) signalling events—TAC1—Parkinson's disease	1.67e-05	0.00706	CbGpPWpGaD
Hydroxyzine—HRH1—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	1.63e-05	0.00692	CbGpPWpGaD
Hydroxyzine—CYP2D6—Biological oxidations—GSTA4—Parkinson's disease	1.57e-05	0.00664	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metapathway biotransformation—GSTA4—Parkinson's disease	1.54e-05	0.00655	CbGpPWpGaD
Hydroxyzine—HRH1—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	1.51e-05	0.00639	CbGpPWpGaD
Hydroxyzine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—Parkinson's disease	1.49e-05	0.00632	CbGpPWpGaD
Hydroxyzine—HRH1—G alpha (q) signalling events—ADRBK1—Parkinson's disease	1.48e-05	0.00626	CbGpPWpGaD
Hydroxyzine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	1.47e-05	0.00623	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—GRM4—Parkinson's disease	1.43e-05	0.00608	CbGpPWpGaD
Hydroxyzine—CYP2D6—Biological oxidations—MAOB—Parkinson's disease	1.4e-05	0.00592	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—PENK—Parkinson's disease	1.36e-05	0.00577	CbGpPWpGaD
Hydroxyzine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRBK1—Parkinson's disease	1.32e-05	0.0056	CbGpPWpGaD
Hydroxyzine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	1.31e-05	0.00554	CbGpPWpGaD
Hydroxyzine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	1.29e-05	0.00547	CbGpPWpGaD
Hydroxyzine—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	1.26e-05	0.00535	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—PDYN—Parkinson's disease	1.24e-05	0.00527	CbGpPWpGaD
Hydroxyzine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	1.22e-05	0.00519	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—DGKQ—Parkinson's disease	1.19e-05	0.00506	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—GRM5—Parkinson's disease	1.16e-05	0.0049	CbGpPWpGaD
Hydroxyzine—HRH1—G alpha (q) signalling events—EDN1—Parkinson's disease	1.15e-05	0.00486	CbGpPWpGaD
Hydroxyzine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	1.12e-05	0.00475	CbGpPWpGaD
Hydroxyzine—HRH1—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	1.11e-05	0.00469	CbGpPWpGaD
Hydroxyzine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	1.11e-05	0.00469	CbGpPWpGaD
Hydroxyzine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	1.1e-05	0.00468	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—GPR37—Parkinson's disease	1.08e-05	0.00459	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—DGKQ—Parkinson's disease	1.08e-05	0.00459	CbGpPWpGaD
Hydroxyzine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	1.08e-05	0.00459	CbGpPWpGaD
Hydroxyzine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	1.05e-05	0.00444	CbGpPWpGaD
Hydroxyzine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	1.02e-05	0.00434	CbGpPWpGaD
Hydroxyzine—HRH1—G alpha (q) signalling events—HTR2A—Parkinson's disease	1e-05	0.00425	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—PPP1R1B—Parkinson's disease	9.9e-06	0.0042	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—ADORA2A—Parkinson's disease	9.83e-06	0.00417	CbGpPWpGaD
Hydroxyzine—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	9.49e-06	0.00402	CbGpPWpGaD
Hydroxyzine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	9.48e-06	0.00402	CbGpPWpGaD
Hydroxyzine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	9.48e-06	0.00402	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	9.36e-06	0.00397	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—GRK5—Parkinson's disease	9.04e-06	0.00383	CbGpPWpGaD
Hydroxyzine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	8.96e-06	0.0038	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—HTR1A—Parkinson's disease	8.53e-06	0.00362	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—TAC1—Parkinson's disease	8.4e-06	0.00356	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—DRD1—Parkinson's disease	8.24e-06	0.00349	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—GRK5—Parkinson's disease	8.21e-06	0.00348	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—GRM4—Parkinson's disease	8.11e-06	0.00344	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—DRD3—Parkinson's disease	7.98e-06	0.00338	CbGpPWpGaD
Hydroxyzine—CYP2D6—Biological oxidations—COMT—Parkinson's disease	7.86e-06	0.00333	CbGpPWpGaD
Hydroxyzine—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	7.83e-06	0.00332	CbGpPWpGaD
Hydroxyzine—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	7.81e-06	0.00331	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	7.76e-06	0.00329	CbGpPWpGaD
Hydroxyzine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	7.75e-06	0.00328	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—VPS35—Parkinson's disease	7.72e-06	0.00327	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	7.72e-06	0.00327	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—PENK—Parkinson's disease	7.68e-06	0.00326	CbGpPWpGaD
Hydroxyzine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	7.59e-06	0.00322	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—GRM4—Parkinson's disease	7.36e-06	0.00312	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—DRD2—Parkinson's disease	7.22e-06	0.00306	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—HTR7—Parkinson's disease	7.22e-06	0.00306	CbGpPWpGaD
Hydroxyzine—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	7.19e-06	0.00305	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	7.09e-06	0.00301	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—PDYN—Parkinson's disease	7.03e-06	0.00298	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—PENK—Parkinson's disease	6.98e-06	0.00296	CbGpPWpGaD
Hydroxyzine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	6.64e-06	0.00281	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—GRM5—Parkinson's disease	6.53e-06	0.00277	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—DGKQ—Parkinson's disease	6.4e-06	0.00271	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—GPR37—Parkinson's disease	6.4e-06	0.00271	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—PDYN—Parkinson's disease	6.38e-06	0.00271	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—GRM5—Parkinson's disease	5.93e-06	0.00252	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—PPP1R1B—Parkinson's disease	5.85e-06	0.00248	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—EDN1—Parkinson's disease	5.78e-06	0.00245	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—ADORA2A—Parkinson's disease	5.56e-06	0.00236	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—RIT2—Parkinson's disease	5.11e-06	0.00217	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—MCCC1—Parkinson's disease	5.1e-06	0.00216	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—ND3—Parkinson's disease	5.1e-06	0.00216	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—HTR2A—Parkinson's disease	5.05e-06	0.00214	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—ADORA2A—Parkinson's disease	5.05e-06	0.00214	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—GRK5—Parkinson's disease	4.85e-06	0.00206	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—HTR1A—Parkinson's disease	4.82e-06	0.00204	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—TALDO1—Parkinson's disease	4.79e-06	0.00203	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—OMD—Parkinson's disease	4.79e-06	0.00203	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—TAC1—Parkinson's disease	4.75e-06	0.00201	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—DRD1—Parkinson's disease	4.66e-06	0.00197	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	4.55e-06	0.00193	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—DRD3—Parkinson's disease	4.51e-06	0.00191	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—HTR1A—Parkinson's disease	4.38e-06	0.00186	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—GRM4—Parkinson's disease	4.35e-06	0.00184	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—GCH1—Parkinson's disease	4.34e-06	0.00184	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—TAC1—Parkinson's disease	4.31e-06	0.00183	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—DRD1—Parkinson's disease	4.23e-06	0.00179	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—ADRBK1—Parkinson's disease	4.21e-06	0.00179	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—MAG—Parkinson's disease	4.12e-06	0.00175	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—PENK—Parkinson's disease	4.12e-06	0.00175	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—DRD3—Parkinson's disease	4.09e-06	0.00174	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—DRD2—Parkinson's disease	4.08e-06	0.00173	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—HTR7—Parkinson's disease	4.08e-06	0.00173	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—GBA—Parkinson's disease	3.86e-06	0.00164	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—FBP1—Parkinson's disease	3.86e-06	0.00164	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—DBH—Parkinson's disease	3.86e-06	0.00164	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—ADRBK1—Parkinson's disease	3.82e-06	0.00162	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—PDYN—Parkinson's disease	3.77e-06	0.0016	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—DRD2—Parkinson's disease	3.7e-06	0.00157	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—HTR7—Parkinson's disease	3.7e-06	0.00157	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—GFAP—Parkinson's disease	3.54e-06	0.0015	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—GRM5—Parkinson's disease	3.51e-06	0.00149	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—EDN1—Parkinson's disease	3.26e-06	0.00138	CbGpPWpGaD
Hydroxyzine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	3.11e-06	0.00132	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—FGF20—Parkinson's disease	3.07e-06	0.0013	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—ADORA2A—Parkinson's disease	2.98e-06	0.00126	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—EDN1—Parkinson's disease	2.96e-06	0.00126	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—HTR2A—Parkinson's disease	2.86e-06	0.00121	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—DDC—Parkinson's disease	2.84e-06	0.0012	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—INSR—Parkinson's disease	2.75e-06	0.00117	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—GSTA4—Parkinson's disease	2.68e-06	0.00114	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—FGB—Parkinson's disease	2.6e-06	0.0011	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—HTR2A—Parkinson's disease	2.59e-06	0.0011	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—HTR1A—Parkinson's disease	2.59e-06	0.0011	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—TAC1—Parkinson's disease	2.55e-06	0.00108	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—DRD1—Parkinson's disease	2.5e-06	0.00106	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—DRD3—Parkinson's disease	2.42e-06	0.00103	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	2.41e-06	0.00102	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—MAOB—Parkinson's disease	2.39e-06	0.00101	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—ADRBK1—Parkinson's disease	2.26e-06	0.000958	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—HTR7—Parkinson's disease	2.19e-06	0.000928	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—DRD2—Parkinson's disease	2.19e-06	0.000928	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—IGF2—Parkinson's disease	1.83e-06	0.000777	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	1.77e-06	0.000751	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—EDN1—Parkinson's disease	1.75e-06	0.000743	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.74e-06	0.000739	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.62e-06	0.000688	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—NGF—Parkinson's disease	1.61e-06	0.000682	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.6e-06	0.00068	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—TH—Parkinson's disease	1.58e-06	0.000671	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	1.53e-06	0.00065	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.52e-06	0.000644	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—APOE—Parkinson's disease	1.42e-06	0.000604	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—COMT—Parkinson's disease	1.34e-06	0.00057	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.34e-06	0.000568	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.34e-06	0.000566	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.32e-06	0.00056	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.27e-06	0.000537	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.23e-06	0.000522	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—INS—Parkinson's disease	1.22e-06	0.000516	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.18e-06	0.000499	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.09e-06	0.000461	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—APOE—Parkinson's disease	1.01e-06	0.000429	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—CASP3—Parkinson's disease	9.06e-07	0.000384	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—IL6—Parkinson's disease	9e-07	0.000382	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—INS—Parkinson's disease	8.65e-07	0.000367	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	8.33e-07	0.000353	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—IL6—Parkinson's disease	5.32e-07	0.000225	CbGpPWpGaD
